LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Stock List・Abbott Laboratories

Search

Abbott Laboratories

Closed

SectorHealthcare

90.7 4.07

Overview

Share price change

24h

Current

Min

87.01

Max

91.41

Key metrics
By Trading Economics
Income	-699M 1.1B
Sales	-295M 11B
P/E Sector Avg	24.588 49.888
EPS	1.15
Dividend yield	2.85
Profit margin	9.647
Employees	122,000
EBITDA	-980M 1.8B

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+31.92% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	2.85% 2.38%
Next Earnings	16 Jul 2026
Next Dividend date	14 Aug 2026
Next Ex Dividend date	14 Jul 2026

Market Stats
By TradingEconomics
Market Cap	-22B 153B
Previous open	86.63
Previous close	90.7

News Sentiment

By Acuity

28%

72%

66 / 344 Healthcare

Abbott Laboratories Chart

Past performance is not a reliable indicator of future results.

Related News

3 Jun 2026, 13:49 UTC

Earnings

Major Market Movers

MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion

16 Apr 2026, 15:13 UTC

Earnings

Major Market Movers

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

16 Apr 2026, 12:23 UTC

Earnings

Major Market Movers

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

22 Jan 2026, 18:36 UTC

Earnings

Major Market Movers

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

16 Apr 2026, 20:23 UTC

Earnings

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 Apr 2026, 16:15 UTC

Earnings

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 Apr 2026, 14:00 UTC

Market Talk

Earnings

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

16 Apr 2026, 13:59 UTC

Market Talk

Earnings

Abbott Laboratories Has Disappointing Quarter -- Market Talk

16 Apr 2026, 12:05 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

16 Apr 2026, 11:32 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs 1Q Sales $11.16B >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs 1Q Net $1.08B >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs 1Q Adj EPS $1.15 >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

16 Apr 2026, 11:30 UTC

Earnings

Acquisitions, Mergers, Takeovers

Abbott Labs 1Q EPS 61c >ABT

11 Apr 2026, 00:00 UTC

Earnings

Acquisitions, Mergers, Takeovers

Big Yachts, Big Bucks -- Barrons.com

23 Mar 2026, 12:50 UTC

Acquisitions, Mergers, Takeovers

Abbott Completes Acquisition Of Exact Sciences >ABT

20 Mar 2026, 13:01 UTC

Acquisitions, Mergers, Takeovers

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

20 Mar 2026, 13:00 UTC

Acquisitions, Mergers, Takeovers

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

28 Jan 2026, 14:48 UTC

Earnings

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

23 Jan 2026, 16:59 UTC

Earnings

Correction to Abbott Stock Drops Article on Jan. 22

22 Jan 2026, 20:42 UTC

Earnings

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 Jan 2026, 16:19 UTC

Earnings

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 Jan 2026, 15:22 UTC

Earnings

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

22 Jan 2026, 14:41 UTC

Hot Stocks

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

22 Jan 2026, 14:08 UTC

Market Talk

Earnings

Abbott Posts Disappointing 4Q -- Market Talk

Peer Comparison

Price change

Abbott Laboratories Forecast

Price Target

By TipRanks

31.92% upside

12 Months Forecast

Average 119.76 USD 31.92%

High 143 USD

Low 92 USD

Based on 20 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

20 ratings

16

Buy

4

Hold

0

Sell

Based on 20 analysts giving stock ratings to Abbott Laboratories - Dist in the past 3 months.

Sentiment

By Acuity

66 / 344 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Other stocks from the sector

LLY

Eli Lilly and Co.

1,125.18

JNJ

Johnson and Johnson

228.23

ABBV

AbbVie Inc

224.88

UNH

UnitedHealth Group Inc

396.79

MRK

Merck & Co Inc.

120.25

Live chat